February 2002

Grant Results

SUMMARY

In 1999, the California Collaborative Center for Substance Abuse Policy Research, San Francisco, organized and convened a scientific conference, and preceding on substance abuse policy research.

The University of California, San Francisco Institute for Health & Aging and Institute for Health Policy Studies, in conjunction with Haight Ashbury Free Clinics, Inc., established the Collaborative Center for Substance Abuse Policy Research in 1997 to promote informed decision-making on public and private substance abuse policy in California through timely, scholarly, and objective research.

Key Results

  • The symposium and conference, held May 20–23, 1999, in San Francisco were the first major public activities of the Collaborative Center for Substance Abuse Policy Research. The scientific conference — "Critical Issues in Addiction" — focused on:
    • The science of addiction.
    • Prescription drug abuse among the elderly.
    • Access to addiction treatment.

    H. Westley Clark, M.D. director of the federal Center for Substance Abuse Treatment, gave the keynote presentation on federal drug policy.

    Eighteen other presenters spoke at the conference, discussing topics, which included the neurology of substance abuse, the economic costs, and age-related pharmacologic issues.

    The conference proceedings appeared in the October–December 2000 issue of the Journal of Psychoactive Drugs, a peer-reviewed journal.

Funding
The Robert Wood Johnson Foundation (RWJF) provided partial support for the conference with a grant of $49,951 between February 1999 and November 1999.

 See Grant Detail & Contact Information
 Back to the Table of Contents


THE SYMPOSIUM AND CONFERENCE

The symposium and conference, held May 20–23, 1999, in San Francisco were CCCSAPR's first major public activities.

At the preliminary organizational symposium, attendees established a Center Steering Committee and set an overall agenda for coordinating CCCSAPR research. (See the Appendix for a list of steering committee members.) Attendees included all primary speakers at the scientific conference, principal investigators of planned and existing CCCSAPR research projects, and representatives of government agencies, medical associations, and research entities concerned with substance abuse policy research.

The scientific conference — "Critical Issues in Addiction" — focused on:

  1. the science of addiction
  2. prescription drug abuse among the elderly
  3. access to addiction treatment.

H. Westley Clark, M.D., director of the federal Center for Substance Abuse Treatment, gave the keynote presentation on federal drug policy. Eighteen other presenters spoke at the conference, discussing topics, which included the neurology of substance abuse, the economic costs, and age-related pharmacologic issues.

The organizers issued news releases on the conference and symposium. The conference proceedings appeared in the October–December 2000 issue of the Journal of Psychoactive Drugs, a peer-reviewed journal. The International Society on Addiction Medicine reported on the symposium and conference in its International Addiction Infoline newsletter. (See the Bibliography for a complete list of presentations and communications activities.)

Following these meetings, CCCSAPR held a second scientific conference — "Substance Abuse: From Research to Clinical Practice" — in May 2000. On June 8–9, 2001, CCCSAPR held a conference entitled "Therapeutic Jurisprudence: Integration of Prevention, Treatment, and Research," which addressed the medicalization of substance abuse treatment and its impact on prevention and research initiatives. The organization has also established a Web page within the IHA Web site with information on its objectives and activities.

Other Funding

Other funding for the conference came from the federal Center for Substance Abuse Treatment, Institute for Health & Aging at UCSF, and Haight Ashbury Free Clinics. The California Medical Association, California Society of Addiction Medicine, American Society of Addiction Medicine, San Francisco Medical Society, and University of California at San Francisco provided free advertising.

 Back to the Table of Contents


GRANT DETAILS & CONTACT INFORMATION

Project

Substance Abuse Policy Research Symposium

Grantee

University of California, San Francisco, School of Nursing (San Francisco,  CA)

  • Amount: $ 49,951
    Dates: February 1999 to November 1999
    ID#:  035859

Contact

Carroll L. Estes, Ph.D.
(415) 476-3236
cestes@itsa.ucsf.edu

Web Site

http://nurseweb.ucsf.edu/iha/Programs/cccsapr.htm

 Back to the Table of Contents


APPENDICES


Appendix 1

(Current as of the time of the grant; provided by the grantee organization; not verified by RWJF.)

California Collaborative Center for Substance Abuse Policy Research Steering Committee

M. Douglas Anglin, Ph.D.
Founding Director and Co-Director
UCLA Drug Abuse Research Center
Los Angeles, Calif.

Vivian B. Brown, Ph.D.
President and CEO
Prototypes
Culver City, Calif.

Sarah Calhoun
Haight Ashbury Free Clinics
San Francisco, Calif.

David Cohn
Medical Director, Substance Abuse Services
Alta Bates Medical Center/Psychiatry
Berkeley, Calif.

David Deitch, Ph.D.
Department of Psychiatry
University of California, San Diego
La Jolla, Calif.

Patricia Ebener
Rand Corporation
Drug Policy Research Center
Santa Monica, Calif.

Phyllis Ellickson, Ph.D.
Director, Center for Research on
Maternal, Child and Adolescent Health
Santa Monica, Calif.

Carroll Estes, Ph.D.
Institute for Health & Aging
University of California, San Francisco
San Francisco, Calif.

Alice Gleghorn, Ph.D.
San Francisco Department of Public Health
Community Substance Abuse Services
San Francisco, Calif.

Joseph Guydish, Ph.D.
Institute for Health Policy Studies
University of California, San Francisco
San Francisco, Calif.

Sharon M. Hall, Ph.D.
Professor In-Residence and Vice Chair
University of California, San Francisco
ATOD Policy Research
San Francisco, Calif.

Martin Iguichi
Rand Corporation
Drug Policy Research Center
Santa Monica, Calif.

Gail Jara
California Society of Addiction Medicine
Oakland, Calif.

Marty Jessup, RN
Consultant, Division of Substance Abuse and
Addiction Medicine
Department of Psychiatry, San Francisco General Hospital
Oakland, Calif.

Lori Koran, M.D.
Division of Clinical Pharmacology and
Experimental Therapeutics
San Francisco General Hospital
San Francisco, Calif.

Philip R. Lee, M.D.
Professor Emeritus
University of California, San Francisco
Institute for Health Policy Studies
San Francisco, Calif.

Walter Ling, M.D.
Professor of Psychiatry and
Chief of Substance Abuse Program
University of California, Los Angeles
Los Angeles, Calif.

Amanda Noble
Senior Research Scientist
Public Health Institute
Davis, Calif.

Joe Ossmann
Acting Director
State of California, Department of Corrections
Office of Substance Abuse Program
Sacramento, Calif.

Richard A. Rawson, Ph.D.
Co-Director, UCLA Drug Abuse Research Center
University of California, Los Angeles
Los Angeles, Calif.

Rick Seymour
CCCSAPR Coordinator
San Francisco, Calif.

David Smith, M.D.
President
Haight Ashbury Free Clinics
San Francisco, Calif.

Jim Stillwell, Acting Director
Community Substance Abuse Services
San Francisco Department of Public Health
San Francisco, Calif.

Donald R. Wesson, M.D.
Friend Research Associates
Berkeley, Calif.

Friedman D. Wittman, Ph.D.
University of California, Berkeley
Institute for Study of Social Change
Berkeley, Calif.

Nancy Young
Children and Families Futures
Irvine, Calif.

Marie Christine Yue
Administrative Assistant
Institute for Health & Aging
University of California, San Francisco
San Francisco, Calif.

Elaine Zahnd
Senior Research Scientist
Public Health Institute
Berkeley, Calif.

Joan Zweben, Ph.D.
School of Medicine
University of California, San Francisco
San Francisco, Calif.

 Back to the Table of Contents


BIBLIOGRAPHY

(Current as of date of this report; as provided by grantee organization; not verified by RWJF; items not available from RWJF.)

Articles

"Proceedings of Critical Issues in Addiction Conference, May 21–23, 1999." Journal of Psychoactive Drugs, 32(October–December): 2000.

Sponsored Conferences

"Critical Issues in Addiction," May 21–23, 1999, San Francisco, Calif. Attended by 180 researchers, treatment personnel, and policymakers. One keynote presentation and 18 other presentations.

Keynote Presentation

  • H. Westley Clark, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration (Washington, D.C.), "Federal Drug Treatment Policy."

Presentations

  • M. Douglas Anglin, Drug Abuse Research Center, University of California, Los Angeles (Los Angeles, Calif.), "Addiction and Treatment Careers: Taking a Longitudinal Perspective."
  • David Cohn, Alta Bates Medical Center (Berkeley, Calif.), "Alcohol and Addiction in the Elderly."
  • David A. Deitch, Addiction Technology Transfer Center, University of California, San Diego (San Diego, Calif.), "Overview of the Crime/Drug Connection and Promising In-Custody Treatment Approaches."
  • Ivan Diamond, Ernest Gallo Clinic and Research Center, San Francisco General Hospital, University of California, San Francisco (San Francisco, Calif.), "Neurobiology of Alcoholism and Substance Abuse."
  • Joseph Elson, Haight Ashbury Free Clinics (San Francisco, Calif.), "Treatment Issues at HAFCI."
  • Carroll Estes, Institute on Health & Aging, University of California, San Francisco (San Francisco, Calif.), "Overview of CCCSAPR."
  • Howard Fields, Department of Neurology, University of California, San Francisco (San Francisco, Calif.), "Current Research in the Neurology of Substance Abuse."
  • Alice Gleghorn, San Francisco Department of Public Health (San Francisco, Calif.), "Report on the Bridge Conferences (Risk Reduction)."
  • Joseph Guydish, Institute for Health Policy Studies, University of California, San Francisco (San Francisco, Calif.), "Preliminary Research Findings: San Francisco Treatment on Demand."
  • Marty Jessup, Department of Psychiatry, San Francisco General Hospital, University of California, San Francisco (San Francisco, Calif.), "Treatment Barriers for Pregnant, Drug Dependent Women: Empathetic Public Policy."
  • Phil Lee, Institute for Health Policy Studies, University of California, San Francisco (San Francisco, Calif.), "CCCSAPR Policy Priorities."
  • Walter Ling, Department of Psychiatry and Behavioral Science, University of California, Los Angeles (Los Angeles, Calif.), "Assessing Prescription Drug Abuse in Older Adults."
  • Richard Rawson, Drug Abuse Research Center, University of California, Los Angeles (Los Angeles, Calif.), "Current Developments in the Treatment of Methamphetamine and Cocaine Addiction."
  • Dorothy Rice, Institute for Health & Aging, University of California, San Francisco (San Francisco, Calif.), "Economic Costs of Substance Abuse."
  • Jim Sorenson, San Francisco General Hospital, University of California, San Francisco (San Francisco, Calif.), "Bridging the Gap Between Treatment and Research."
  • G. Douglas Talbott, American Society of Addiction Medicine (Chevy Chase, Md.), "Evaluation and Drug Abuse Treatment of Elderly Health Care Professionals."
  • Donald R. Wesson, American Society of Addiction Medicine (Chevy Chase, Md.), "Age-Related Pharmacology Issues."
  • Joan Ellen Zweben, School of Medicine, University of California, San Francisco (San Francisco, Calif.), "Chronic Mentally Ill Substance Abusers."

Print Coverage

"New Policy Research Center for California," in the California Society of Addiction Medicine Newsletter, Summer 1999.

"Report of the Critical Issues in Addiction Conference, May 21–23, 1999, San Francisco, California," in International Addiction Infoline, June 1999.

"Report on Critical Issues in Addiction Conference," in the Journal of Psychoactive Drugs, April–June 1999.

"Report on Critical Issues in Addiction Conference," in Multidisciplinary Association for Psychedelic Studies, Summer 1999.

 Back to the Table of Contents


Report prepared by: Mike Meagher
Reviewed by: Richard Camer
Reviewed by: Robert Narus
Program Officer: Barbara Matacera Barr